U.S. Markets close in 3 hrs 48 mins

Moderna Inc (MRNA) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Moderna Inc (MRNA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Moderna Inc has a market cap of $6.57 billion; its shares were traded at around $19.97 .

For the last quarter Moderna Inc reported a revenue of $135.1 million, compared with the revenue of $108.4 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $135.1 million, a decrease of 34.4% from the previous year.


The reported loss per diluted share was $1.17 for the year, compared with the loss per share of $0 in the previous year. The Moderna Inc had an operating margin of -305.97%, compared with the operating margin of -130.87% a year before. The 10-year historical median operating margin of Moderna Inc is -168.66%. The profitability rank of the company is 2 (out of 10).

For the complete 20-year historical financial data of MRNA, click here.

This article first appeared on GuruFocus.